US EditionINTERIM ANALYSIS OF 2-LEVEL BAGUERA® C IDE STUDY MEETS THRESHOLD FOR NON-INFERIORITY - PressReach
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
INTERIM ANALYSIS OF 2-LEVEL BAGUERA® C IDE STUDY MEETS THRESHOLD FOR NON-INFERIORITY - PressReach
GENEVA, April 16, 2025 /PRNewswire/ — Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE study, which showed that BAGUERA® C, its cervical disc prosthesis, met the threshold for a non-inferiority claim against the study control. Last month, Spineart announced that its interim analysis for its 1-level BAGUERA® C IDE study had also showed th…
Interim Analysis Of 2-Level BAGUERA® C IDE Study Meets Threshold For Non-Inferiority – Ortho Spine News
GENEVA, April 16, 2025 /PRNewswire/ — Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE study, which showed that BAGUERA® C, its cervical disc prosthesis, met the threshold for a non-inferiority claim against the study control. Last month, Spineart announced that its interim analysis for its 1-level BAGUERA® C IDE study had also showed that
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
